Combined modality treatment for osteosarcoma occurring as a second malignant disease

Journal of Clinical Oncology

Volumn 17, Issue 4, 1999, Pages 1164-1174

  Bielack, Stefan S ^a   Kempf Bielack, Beate ^a   Heise, Ulrich ^a   Schwenzer, Dorothea ^a   Winkler, Kurt ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; INFANT; LYMPHOMA; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETINOBLASTOMA; SARCOMA; SECOND CANCER; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032906395     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.4.1164     Document Type: Article

References (54)

1. Meadows AT, Baum E, Fossati-Bellani F, et al: Second malignant neoplasms in children: An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985
2. Hawkins MM, Draper GJ, Kingston JE: Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 56:339-347, 1987
3. Newton WA Jr, Meadows AT, Shimada H, et al: Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer 67:193-201, 1991
4. Kaatsch P, Michaelis J: Zweitmalignome nach malignen Erkrankungen im Kindesalter. Klin Pädiatr 207:158-163, 1995
5. Moll AC, Imhof SM, Bouter LM, et al: Second primary tumors in patients with retinoblastoma: A review of the literature. Ophthalmic Genet 18:27-34, 1997
6. Varley JM, Evans DG, Birch JM: Li-Fraumeni syndrome: A molecular and clinical review. Br J Cancer 76:1-14, 1997
7. Huvos AG, Woodward HQ, Cahan WG, et al: Postradiation osteogenic sarcoma of bones and soft tissues. Cancer 55:1244-1255, 1985
8. Robinson E, Neugut AI, Wylie P: Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 80:233-240, 1988
9. Kuttesch JF Jr, Wexler LH, Marcus RB, et al: Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol 14:2818-2825, 1996
10. Hawkins MM: Second primary tumors among survivors of childhood cancer treated with anticancer drugs. IARC Sci Publ 78:231-252, 1986
11. Tucker MA, D'Angio GJ, Boice JD, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987
12. Huvos AG: Bone Tumors: Diagnosis, Treatment, and Prognosis (ed 2). Philadelphia, PA, W.B. Saunders, 1991
13. Rosen G, Nirenberg A, Caparros B, et al: Osteogenic sarcoma: Eight-percent, three-year, disease-free survival with combination chemotherapy (T-7). Natl Cancer Inst Monogr 56:213-220, 1981
14. Winkler K, Beron G, Kotz R, et al: Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a cooperative German/Austrian study. J Clin Oncol 2:617-623, 1984
15. Link MP, Goorin AM, Horowitz M, et al: Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop 270:8-14, 1991
16. Healey JH, Buss D: Radiation and pagetic osteogenic sarcomas. Clin Orthop 270:128-134, 1991
17. Pratt CB, Meyer WH, Rao BN, et al: Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site. Cancer 80:1171-1177, 1997
18. Winkler K, Beron G, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS 82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329-337, 1988
19. Winkler K, Bielack S, Delling G, et al: Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS 86). Cancer 66:1703-1710, 1990
20. Winkler K: COSS-91/COSS-86C. Therapieprotokoll der cooperativen Osteosarkom-Studiengruppe COSS der Gesellschaft für pädiatrische Onkologie und Hämatologie. Hamburg, Germany, the COSS Group, 1991
21. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-120, 1980
22. Salzer-Kuntschik M, Brand G, Delling G: Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologe 4:135-141, 1983
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. Mantel M: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
25. Bechler JR, Robertson WW Jr, Meadows AT, et al: Osteosarcoma as a second malignant neoplasm in children. J Bone Joint Surg Am 74:1079-1083, 1992
26. Pendlebury SC, Bilous M, Langlands AO: Sarcomas following radiation therapy for breast cancer: A report of three cases and a review of the literature. Int J Radiat Oncol Biol Phys 31:405-410, 1995
27. Schwarz RE, Burt M: Radiation-associated malignant tumors of the chest wall. Ann Surg Oncol 3:387-392, 1996
28. Tabone MD, Brunat-Mentigny M, Schmitt C, et al: Radiation-related bone sarcoma: A retrospective study of 24 cases. Med Pediatr Oncol 27:217, 1996 (abstr)
29. Rich DC, Corpron CA, Smith MB, et al: Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg 32:369-372, 1997
30. Bielack S, Wulff B, Delling G, et al: Osteosarcoma of the trunk treated by multimodal therapy: Experience of the cooperative osteosarcoma study group COSS. Med Pediatr Oncol 24:6-12, 1995
31. Strong LC, Stine M, Norsted TL: Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 79:1213-1220, 1987
32. Huvos AG: Osteogenic sarcoma of bones and soft tissues in older persons: A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442-1449, 1986
33. Smith J: Postradiation sarcoma of bone in Hodgkin disease. Skeletal Radiol 16:524-532, 1987
34. Brady MS, Gaynor JJ, Brennan MF: Radiation-associated sarcoma of bone and soft tissue. Arch Surg 127:1379-1385, 1992
35. Friend SH, Bernards R, Rogelj S, et al: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986
36. Russo CL, McIntyre J, Goorin AM, et al: Secondary breast cancer in patients presenting with osteosarcoma: Possible involvement of germline p53 mutations. Med Pediatr Oncol 23:354-358, 1994
37. Schwarz MB, Burgess LP, Fee WE Jr, et al: Postirradiation sarcoma in retinoblastoma: Induction or predisposition? Acta Otolaryngol Head Neck Surg 114:640-644, 1988
38. Smith LM, Donaldson SS: Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. Oncology (Huntingt) 5:135-141, 1991
39. Fuchs N, Bielack S, Epler D, et al: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893-899, 1998
40. Picci P, Sangiorgi L, Rougraff BT, et al: Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699-2705, 1994
41. Smeele LE, Kostense PJ, vanderWaal I, et al: Effect of chemotherapy on survival of craniofacial osteosarcoma: A systematic review of 201 patients. J Clin Oncol 15:363-67, 1997
42. Kempf-Bielack B, Bielack S, Bieling P, et al: Local failure (LF) of osteosarcoma (OS): Risk factors and prognosis - Results of the cooperative osteosarcoma study group. Proc Am Soc Clin Oncol 15:A1674, 1996 (abstr)
43. Glasser DB, Lane JM: Stage IIB osteogenic sarcoma. Clin Orthop 270:29-39, 1991
44. Smith MB, Xue H, Strong L, et al: Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy. J Pediatr Surg 28:1342-1348, 1993
45. Weatherby RP, Dahlin DC, Ivins JC: Postirradiation sarcoma of bone: Review of 78 Mayo Clinic cases. Mayo Clin Proc 56:294-306, 1981
46. Saeter G, Alvegard TA, Elomaa I, et al: Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study. J Clin Oncol 9:1766-1775, 1991
47. Souhami RL, Craft AW, van der Eijken JW, et al: Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup. Lancet 350:911-917, 1997
48. Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the children's cancer group. J Clin Oncol 15:76-84, 1997
49. Frassica FJ, Sim FH, Frassica DA, et al: Survival and management considerations in postirradiation osteosarcoma and Paget's osteosarcoma. Clin Orthop 270:120-127, 1991
50. Smith LM, Donaldsonn SS, Egbert PR, et al: Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys 17:499-505, 1989
51. Dunkel IJ, Gerald WL, Rosenfield NS, et al: Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: The Memorial Sloan-Kettering experience. Med Pediatr Oncol 30:59-62, 1998
52. Li W, Fan J, Hochhauser D, et al: Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc Natl Acad Sci U S A 92:10436-10440, 1995
53. Feugeas O, Guriec N, Babin-Boilletot A, et al: Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467-72, 1996
54. Davis AM, Bell RS, Goodwin PJ: Prognostic factors in osteosarcoma: A critical review. J Clin Oncol, 12:423-431, 1994